In Silico Study of Phytochemical Compound from Daun Kluwih  (Artocarpus camansi) as an Antidiabetic Targeting Aldose Reductase

Dinar Umaimah Radani; Ignasia Anindya Pintagratia; Anindya Nursanti Syaiful; Fahri Renaldi; Fachrizal Dwi Kautsar; Dhania Novitasari

doi:10.70392/jpns.v3i1.49

Authors

Dinar Umaimah Radani Author
Ignasia Anindya Pintagratia Author
Anindya Nursanti Syaiful Author
Fahri Renaldi Author
Fachrizal Dwi Kautsar Author
Dhania Novitasari Faculty of Pharmacy, Universitas Padjadjaran Author

DOI:

https://doi.org/10.70392/jpns.v3i1.49

Keywords:

Aldose Reductase, Artocarpus camansi, Diabetes Mellitus

Abstract

Diabetes Mellitus (DM) is a disease characterized by increased blood glucose levels. The most common type of diabetes is type 2 diabetes mellitus. Aldose Reductase is an enzyme that works in the polyol pathway. The polyol pathway is the pathway where glucose is metabolized by aldose reductase into sorbitol. The end result of this polyol pathway will accumulate in the tissue so that there is a disruption of the osmolarity of the basal membrane which can cause complications of diabetes mellitus. Therefore, the activity of the aldose reductase enzyme must be inhibited, one of which is using chemical compounds so that complications such as cataracts do not occur. Tests conducted in this study include Lipinski's RO5, ADMETox, pharmacophore screening, and molecular docking. From the test results, it was found that the most potential compound in treating Diabetes Mellitus is Cycloartenol Acetate.

References

Maghfuri, A. Perawatan Luka Diabetes Melitus. Jakarta: Salemba Medika. 2016.

Manalu, R.T., Safitri, H., Sari, H.P., Devina, R., Irnawati, I. Liliwana, E.A. Analisis In-Silico Penghambatan Main Protease (MPRO) pada SARS-CoV-2 oleh Senyawa Aktif Teh Hijau (Camelia sinensis). Jurnal Farmagazine 2021, 8(2), 1.

Saputri, K.E., Fakhmi, N., Kusumaningtyas, E., Priyatama, D., Santoso, B. Docking Molekular Potensi Anti Diabetes Melitus Tipe 2 Turunan Zerumbon sebagai Inhibitor Aldosa Reduktase dengan Autodock-Vina. Chimica et Natura 2016, 4(1), 16– 20.

Bicaldo, P.J. Artocarpus camansi blanco: A review on its traditional use, nutritional value, phytochemistry, and pharma-cology. Preprints, 2022.

Silalahi, M. Keluwih (Artocarpus camansi Blanco): Potential utilization as foodstuff and its bioactivity. GSC Biological and Pharmaceutical Sciences 2022, 19(2), 310-315.

Widarso, N.Y., Mahwati, A.A., Sibuea, I.I., Ismail, D.P.F., Mahardika, B.S. and Novitasari, D. Targeting Androgen Receptor with Boesenbergia rotunda Phytoconstituents: A Computational-based Perspective. Indonesian Journal of Cancer Chemoprevention 2026, 16(1), 29-43.

Ismail, D.P., Christella, A., Salsabila, N.F., Angela, A., Muljono, F.O., Fardhan, F.M., Novitasari, D. The bioactive compounds in bilimbi leaves (Averrhoa bilimbi L.) as natural-based anticancer targeting on VEGFR-2: In silico studies. Notulae Scientia Biologicae 2025, 17(1), 12289-12289.

Saputri, K.E., Fakhmi, N., Kusumaningtyas, E., Priyatama, D., Santoso, B. Docking molekular potensi anti diabetes melitus tipe 2 turunan zerumbon sebagai inhibitor aldosa reduktase dengan autodock-vina. Chimica et Natura Acta 2016, 4(1), 16-20.

Karami, T.K., Hailu, S., Feng, S., Graham, R., Gukasyan, H.J. Eyes on Lipinski's rule of five: A New “rule of thumb” for physicochemical design space of ophthalmic drugs. Journal of ocular pharmacology and therapeutics 2022, 38(1), 43-55.

Wu, F., Zhou, Y., Li, L., Shen, X., Chen, G., Wang, X., Liang, X., Tan, M., Huang, Z. Computational approaches in preclinical studies on drug discovery and development. Frontiers in Chemistry 2020, 8, 726.

Owoseeni, O.D., Patil, R.B., Phage, P.M., Ogboye, R.M., Ayoola, M.D., Famuyiwa, S.O., Gboyero, F.O., Ndinteh, D.T. and Faloye, K.O. Computational assessment of xanthones from African medicinal plants as aldose reductase inhibi-tors. Computation 2022, 10(9), 146.

Suhadi, A., Rizarullah, R., Feriyani, F. Simulasi docking senyawa aktif daun binahong sebagai inhibitor enzyme aldose reductase. Sel Jurnal Penelitian Kesehatan 2019, 6(2),.55-65.

Patil, R.H., Patil, M.P., Maheshwari, V.L. Antidiabetes constituents, cycloartenol and 24-methylenecycloartanol, from Ficus krishnae. PLoS One 2020, 15(6), e0235221.

Pujirahayu, N., Ritonga, H., Uslinawati., Œ±-Glucosidase inhibitory activity of cycloartane-type triterpenes isolated from Indonesian stingless bee propolis and their structure-activity relationship. Pharmaceuticals 2019, 12(4), 156.

Mylari, B.L., Larson, E.R., Beyer, T.A., Zembrowski, W.J., Aldinger, C.E., Dee, M.F., Siegel, T.W., Singleton, D.H. Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid (zopolrestat) and con-geners. Journal of Medicinal Chemistry 1991, 34(4), 1187-1200.

Cappiello, M., Voltarelli, M., Cecconi, I., Vilardo, P.G., Dal Monte, M., Marini, I., Del Corso, A., Wilson, D.K., Quiocho, F.A., Petrash, J.M., Mura, U. Specifically targeted modification of human aldose reductase by physiological disulfides. Journal of Biological Chemistry 1996, 271(52), 33539-33544.

Jain, A., Vaidya, A., Ravichandran, V., Kashaw, S.K., Agrawal, R.K. Virtual screening, molecular docking and phar-macophore modeling of phytoconstituents of flavones as aldose reductase inhibitors. Journal of Pharmaceutical Research International 2021, 33(52B), 58-71.

Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 2001, 46(1-3), 3-26.

Furman, B.L. Streptozotocin-induced diabetic models in mice and rats. Current Protocols 2021, 1(4), p.e78.

Thomford, N.E., Senthebane, D.A., Rowe, A., Munro, D., Seele, P., Maroyi, A., Dzobo, K. Natural products for drug discovery in the 21st century: innovations for novel drug discovery. International Journal of Molecular Sciences 2018, 19(6), 1578.